propionylcarnitine has been researched along with Carcinoma, Ehrlich Tumor in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abou El-Naga, SA; Calvani, M; Gaballah, HE; Nicolai, R; Salman, TM; Sayed-Ahmed, MM | 1 |
1 other study(ies) available for propionylcarnitine and Carcinoma, Ehrlich Tumor
| Article | Year |
|---|---|
Propionyl-L-carnitine as protector against adriamycin-induced cardiomyopathy.
Topics: Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Cardiomyopathies; Cardiotonic Agents; Carnitine; Doxorubicin; Female; Glutathione; In Vitro Techniques; Male; Malondialdehyde; Mice; Mitochondria, Heart; Oxidation-Reduction; Rats; Rats, Sprague-Dawley | 2001 |